EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JAN 2023
TABLES
132
PAGES
453
EDITION
17
PRICE
USD 5800
CODE
MCP-1534
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What`s New for 2023?
» Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Contract Research Outsourcing Market to Reach $72.1 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Contract Research Outsourcing estimated at US$44.9 Billion in the year 2020, is projected to reach a revised size of US$72.1 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027. Clinical, one of the segments analyzed in the report, is projected to record a 7.4% CAGR and reach US$48.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Discovery segment is readjusted to a revised 6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $18.1 Billion, While China is Forecast to Grow at 9.3% CAGR
The Contract Research Outsourcing market in the U.S. is estimated at US$18.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2027 trailing a CAGR of 9.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.1% and 6.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.Pre-Clinical Segment to Record 6.8% CAGR
In the global Pre-Clinical segment, USA, Canada, Japan, China and Europe will drive the 6.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.3 Billion in the year 2020 will reach a projected size of US$8.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
SELECT PLAYERS
Albany Molecular Research, Inc.; Charles River Laboratories International, Inc.; Covance Clinical Biotech; ICON plc; IQVIA Inc; Jubilant Biosys Ltd.; Laboratory Corporation of America® Holdings; Olon Ricerca Bioscience; PAREXEL International Corp.; Pharmaceutical Product Development, LLC.; Pharmaron; PRA Health Sciences, Inc.; Sygnature Discovery Limited; Syneos Health; SynteractHCR; WuXi AppTec
SEGMENTS
» Service Type (Clinical, Discovery, Pre-Clinical, Laboratory Services) » End-Use (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Academic Institutes)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » India » Rest of Asia-Pacific » Latin America » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Impact of Covid-19 and a Looming Global Recession |
COVID-19 Delivers Mixed Results for Pharmaceutical Research Outsourcing Industry |
Players Focus on Collaborative Approach |
Optimism Reigns in Latter Part of 2020 |
COVID-19 and Implications for Drug Development Regulations & Processes |
Opportunities in COVID-19 Programs |
Parallel Gains for Development & Manufacturing |
Contract Research Outsourcing – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
Contract Research Outsourcing: An Introduction |
Key Service Markets |
Market Dynamics |
Key Therapeutic Areas of Clinical Trial Research |
EXHIBIT: Global Clinical Trial Services Market by Therapeutic Area: 2019 |
Cost Savings Hold Relevance |
Product Innovations & Enhanced Speed |
Access to Expertise & Sophisticated Technology |
Outlook |
Regional Market Analysis |
Future Model of CRO |
COMPETITIVE SCENARIO |
CRO: A Highly Fragmented Market |
EXHIBIT: Leading Players in the Global Contract Research Outsourcing Market (2019): Percentage Breakdown of Revenues by Player |
Partnership Models Pay Returns |
Strategies and Tactical Programs |
Large CROs Seek the Inorganic Growth Route |
Key Opportunities for CROs |
Technological Superiority: An Advantage |
Consolidation to Gain Pace |
Recent Market Activity |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Uptrend in Advanced Medicine Concepts Favors Growth |
Drug Developers Bet on CROs to Sail through Challenging Aspects |
Pharmaceutical & Biopharmaceutical Firms Target Outsourcing |
Gene Therapy Offers Exciting Opportunities for CROs |
COVID-19 Creates a Pause in Gene Therapy Market Growth |
Gene Therapy Set to Witness Rapid Growth Post COVID-19 |
EXHIBIT: Global Gene Therapy Market in US$ Million for Years 2020, 2022, 2024, 2026 |
Increasing Significance of Biologic Drugs Supports Market Demand |
EXHIBIT: Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025 |
COVID-19 Drives Strong Gains for Biologics Activity |
Opportunities Rife in Early Stage Drug Development |
Notable Trends in Pharma/Biopharma R&D Impacting CROs |
Advances in Digital/Technology and its Impact on Clinical Development |
Significant Strides Taken in the Sphere of Current Clinical Research |
Data Quality Oversight (DQO) Undergoes Change |
Pharmacovigilance Set to Grow |
Artificial Intelligence and Machine Learning Gain Interest |
Orphan Drugs to the Fore |
CROs Adapt New Technologies to See More Business in Future |
Streamlining Development of Novel Trial Designs |
Industry Witnesses Increased Spend on R&D Outsourcing |
EXHIBIT: Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025 |
EXHIBIT: Percentage Breakdown of Total Number of Compounds in Pipeline by Phase for Pre-Clinical, Phase I, Phase II and Phase III: 2019 |
Focus on Enhancing Site Selection and Patient Enrollment |
CROs Enter into Alliances to Improve Efficiencies |
Adoption of Digital Technologies Gains Pace |
Toxicology Services Gain Notable Attention |
Pharma Companies Enter into Licensing Agreements with Biotech Companies for New Drug Discovery |
Pharmaceutical & Biopharmaceutical Trends to Support CRO Penetration |
EXHIBIT: Global Biopharma % R&D Outsourcing (2014-2022) |
EXHIBIT: New FDA Drug Approvals (2010-2016): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals |
eClinical Solutions Gain Traction |
Other Noteworthy Market Trends |
Challenges Faced by Contract Research Organizations |
Surging Global Population Offers Increased Growth Opportunities |
EXHIBIT: World Population (in Thousands) by Geographic Region for the Years 2018, 2025, 2040, 2050 |
Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth |
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 |
EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 |
EXHIBIT: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) |
EXHIBIT: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others |
EXHIBIT: World Diabetes and Population Statistics (2019, 2030 & 2045) |
Increasing Healthcare Expenditure and Demand for Generics to Drive Growth |
EXHIBIT: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023 |
EXHIBIT Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023 |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Pre-Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Laboratory Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
Market Overview |
COVID-19 Pandemic: Mixed Bag of Opportunities for CROs |
Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings |
Trial Services Witness Strong Demand |
High Demand for Data Management Services |
Risk-based Monitoring Catches Pace |
Market Analytics |
USA Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
CANADA |
Canada Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
JAPAN |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
Japan Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
CHINA |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
Market Overview |
China Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
EUROPE |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
Market Overview |
Amid Pandemic, CRO Industry in Europe Gears Up for Broad-based Amendments |
Providers Expand Services in Downstream Drug Development |
Market Analytics |
Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Contract Research Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
FRANCE |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
France Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
GERMANY |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
Germany Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
ITALY |
Italy Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
UNITED KINGDOM |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
UK Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
SPAIN |
Spain Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
Spain Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
RUSSIA |
Russia Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
Russia Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
ASIA-PACIFIC |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
Market Overview |
Asia-Pacific to Push Up Volume Share in CRO Market |
R&D Outsourcing in Life Sciences on Rise |
Market Analytics |
Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Contract Research Outsourcing by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for India and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
INDIA |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E) |
Indian CROs Seek Opportunities |
India Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
India Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
India Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
India Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
REST OF ASIA-PACIFIC |
Market Overview |
Australia: Popular Destination for Early Phase Clinical Trials |
Market Analytics |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
LATIN AMERICA |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E) |
Latin America Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
Latin America Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2021 & 2027 |
Rest of World Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2021 & 2027 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com